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Abstract – Despite the presence of a family of defense proteins, Phaseolus vulgaris can be attacked by bruchid
insects resulting in serious damage to stored grains. The two distinct active forms of α-amylase inhibitors, α-AI1
and α-AI2, in P. vulgaris show different specificity toward α-amylases. Zabrotes subfasciatus α-amylase is
inhibited by α-AI2 but not by α-AI1. In contrast, porcine α-amylase is inhibited by α-AI1 but not by α-AI2. The
objective of this work was to understand the molecular basis of the specificity of two inhibitors in P. vulgaris
(α-AI1 and α-AI2) in relation to α-amylases. Mutants of α-AI2 were made and expressed in tobacco plants. The
results showed that all the α-AI2 mutant inhibitors lost their activity against the insect α-amylases but none
exhibited activity toward the mammalian α-amylase. The replacement of His33 of α-AI2 with the α-AI1-like
sequence Ser-Tyr-Asn abolished inhibition of Z. subfasciatus α-amylase. From structural modeling, the conclusion
is that the size and complexity of the amylase-inhibitor interface explain why mutation of the N-terminal loop and
resultant abolition of Z. subfasciatus α-amylase inhibition are not accompanied by gain of inhibitory activity
against porcine α-amylase.
Index terms: Phaseolus vulgaris, α-amylase inhibitors, inhibitor specificity, site directed mutagenesis, structural
modeling.
Mutantes do inibidor-2 de alfa-amilase do feijão-comum para investigação
da especificidade de ligação a alfa-amilases
Resumo – Apesar de possuir uma família de proteínas de defesa, o feijão-comum (Phaseolus vulgaris L.) pode
ser atacado por insetos bruquídeos causando sérios danos aos grãos armazenados. O P. vulgaris possui duas
formas ativas de inibidores de α-amilases, denominadas α-AI1 e α-AI2, que apresentam diferentes especificidades
em relação às α-amilases. A α-amilase de Zabrotes subfasciatus é inibida por α-AI2 mas não por α-AI1.
Em contraste, a α-amilase pancreática de porco é inibida por α-AI1 mas não é por α-AI2. O objetivo deste
trabalho foi entender as bases moleculares da especificidade desses inibidores em relação às α-amilases. Para
tanto, foram construídos mutantes do α-AI2, os quais foram expressados em plantas de fumo. Todos os inibidores
mutantes deixaram de inibir a α-amilase de inseto sem, contudo, passar a exibir atividade contra a α-amilase de
mamífero. Os modelos estruturais explicam por que a substituição de His33 do α-AI2 pela seqüência correspon-
dente do α-AI1 (Ser-Tyr-Asn) aboliu a inibição da α-amilase de Z. subfasciatus. Dos estudos de modelagem
molecular pode-se concluir que o tamanho e a complexidade da interface α-amilase-inibidor explicam por que a
mutação da alça N-terminal e a quebra da atividade inibitória para α-amilase de Z. subfasciatus não levam  ao
ganho de atividade inibitória do mutante em relação à α-amilase de porco.
Termos para indexação: Phaseolus vulgaris, inibidores de α-amilases, especificidade de interação, mutagênese
sítio-dirigida, modelagem molecular.
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Introduction
Alfa-amylase inhibitors (α-AI) occur naturally in many
food plants and are particularly abundant in cereals and
legumes (Franco et al., 2002). Insects gain access to
food sources when they evolve amylases that are not
affected by inhibitors present in the food source, and
plants become resistant when they evolve inhibitors
effective against these insect enzymes. Genes encoding
these inhibitors have been used to make transgenic crops
by gene transfer technology because their expression in
plants is harmful to target insects and pests, interfering
with their digestion, absorption or reproduction, whereas
no antinutritional or toxic effects were observed in rats
fed on transgenic pea expressing the insecticidal bean
α-amylase inhibitor (Pusztai et al., 1999).
In the common bean (Phaseolus vulgaris), α-AI exist
as at least two allelic variants that differ in their
specificity towards α-amylases, despite their high degree
of similarity (78% amino acid sequence identity). Alfa-
amylase inhibitor-1 (α-AI1) is the isoform found in
cultivated beans (Moreno & Chrispeels, 1989) and inhibits
porcine pancreatic α-amylase (PPA), as well as the
α-amylases of the cowpea weevil Callosobruchus
maculatus (CMA) and the azuki bean weevil
(Callosobruchus chinensis) (Kasahara et al., 1996),
but not the amylase of bruchid (Zabrotes subfasciatus)
(ZSA) (Ishimoto & Kitamura, 1989). Alpha-amylase
inhibitor-2 (α-AI2) is found in some wild bean accessions
(Suzuki et al., 1993) and, in contrast, only inhibits ZSA.
 The growth of larvae of two seed feeding beetles,
C. maculates and C. chinensis, is inhibited when the
diet of the larvae contains relatively low levels of
common bean α-AI (Ishimoto & Kitamura, 1989). Pea
transgenic seeds containing up to 0.1%–1.2% of α-AI1
were resistant to cowpea weevils and azuki bean
weevils (Shade et al., 1994). Furthermore, in field trials,
peas expressing α-AI1 were protected against damage
by the pea weevil (Pusztai et al., 1999), suggesting that
gene transfer mechanism can be used to make legumes
resistant to bruchids. Common beans resistant to
Z. subfasciatus have already been produced by
traditional breeding techniques but presently there are
no inhibitors in beans that are effective against
Acanthoscelides obtectus, another important storage
bean insect pest. A better understanding of the molecular
basis of specificity of α-AI and their target amylases
therefore has potential practical benefits.
 In the last ten years, several studies of the interaction
between α-amylase inhibitors and their target enzymes
have been carried out (Pueyo et al., 1993; Mirkov et al.,
1995; Grossi-de-Sá et al., 1997; Takahashi et al., 1999).
Based on the pea lectin structure (Einspahar et al., 1986)
and their own sequence alignments, Mirkov et al. (1995)
constructed an α-AI1 mutant by replacement of the
188WSY190 triplet with GNV producing an inactive
inhibitor. The same triplet was considered later by Gros-
si-de-Sá et al. (1997) in substitutions using the
corresponding α-AI2 sequence. The α-AI2- triplet was
also changed to the α-AI1-like sequence. In both cases
the specificity of the inhibitor remained unchanged.
Research was further stimulated after the crystal
structures of α-AI1 complexed with PPA (Bompard-
Gilles et al., 1996), Tenebrio molitor α-amylase (TMA)
alone (Strobl et al., 1998), and in complex with
α-AI1 (Nahoum et al., 1999), were determined.
The PPA/α-AI1 structure confirmed that interactions
occur primarily by contacts with two inhibitor loops and
revealed an extensive network of direct hydrogen bonds.
Based on these structures, ZSA and the four pairwise
α-AI1 or α-AI2 complexes with PPA or ZSA were
modeled (Silva et al., 2000). Although none of the
interface parameters analyzed were, alone, able to
explain the specificity of inhibitors for their cognate
enzymes, lists of interface forming residues were defined
as targets for experimental efforts toward specificity
alteration via site-directed mutagenesis.
The main goal of this work was to understand the
molecular basis of the specificity of α-AI1 and α-AI2
inhibitors in P. vulgaris in relation to α-amylases.
Material and Methods
Construction of the mutants by PCR mutagenesis
The PCR (polymerization chain reaction) techniques,
as described in Mole et al. (1989) and Landt et al. (1990),
were used to construct the mutants (M1, M2, M3 e M4)
of the α-AI2 gene. In each case, the substitution assumed
the same correspondent amino acid sequence like in
α-AI1 (Table 1). For construction of the first mutant
(M1), the cDNA (complementary deoxyribonucleic acid)
of α-AI2 on the pUC8 plasmid (Grossi-de-Sá et al.,
1997) was used as template; the amino acids serine (Ser)
and tyrosine (Tyr) were inserted between positions 32
and 33, and His33 was replaced by asparagine (Asn)
(SYH33N). These residues are involved in the N-ter-
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minal loop and this mutation was repeated in all other
mutants.The M1 mutant was used as template
to construct the M2 mutant where Gln71 was repla-
ced by histidine (Q71H); this residue is invol-
ved in binding to α-amylase but is outside of the two
main interacting loops. The M1 mutant was also
used to construct the M3 mutant, but in this
case the additional  mutation involved the C-terminal
loop, where the His175, Glu176, Tyr177 and Phe179 were
replaced by tyrosine, glutamine, tryptophan and tyro-
sine, respectively. The M4 triple mutant was
constructed to contain all the mutations introduced
in the other mutants. The primers used to per-
form the mutations were α-AI2PR1: 5’CATAGAGT
CCACTGTATTATAGGATAGTTGTAAGTAGCC3’;
α-AI2PR2: 5’TGCTTCGCGGTGAGTGGTGATATT
CA3’ and α-AI2PR3: 5’GCCATCTCAGGGGTTTATC
AATGGAGCTATGAAACGAGAGACGTG3’, with
the mutated nucleotides in bold letters. The primers of
the 3’ and 5’ α-AI2 sites, in a sense (5’CCGAATTCAT
GGCTTCCTCCAACTTA3’) or in antisense
(5 ’CTAGAGGATATTGTTGAGGAGGAT3’)
orientation, were combined in each case to obtain the
megaprimer (intermediary step) or the whole gene.
The PCR products were digested by EcoRI, gel
purified and ligated into pGEMT-easy (Promega
Corporation, Madison, Wis., USA). In each cloning step,
several clones of each construction were sequenced to
confirm that no errors had been produced. To guarantee
maximum fidelity, the Pfu enzyme (Promega) was used
in the reactions. The BsmI and PstI sites were introduced
(by PCR) into the ends of both the wild-type and mutants
versions of the α-AI2 gene to facilitate the fusion of
this gel purified fragment (750 bp) into plasmid pTA-2
(Grossi-de-Sá et al., 1997), containing the PHA-L
(phytohemaglutinin) (536 bp) seed-specific promoter.
Finally, the HindIII-EcoRI chimeric (PHA/wild-type or
PHA/α-AI2 mutants) cDNA fragments were cloned in
respective sites into the plant transformation vector
pCAMBIA 1390 (Cambia GPO, Camberra, Australia)
containing the nopaline synthase transcriptional (NOS)
terminator.
Tobacco transformation
The above mentioned vectors were introduced into
tobacco (Nicotiana tabacum cv. Xanthi) to express the
protein in the seeds. The binary vectors were transferred
to Agrobacterium tumefaciens GV3101PMP90 (Koncz
& Schell, 1986) using heat-shock method (Brasileiro &
Carneiro, 1998). Sterilized leaf explants were
transformed by a simplified version of the leaf-disc
method (Horsh et al., 1985). Five different cultures of
Agrobacterium harboring each construction were
grown in 5 mL YEB medium (Vervliet et al., 1975)
supplemented with rifampicin (100 µg/mL), gentamicin
(50 µg/mL) and kanamycin (100 µg/mL), for 16 hours,
28±2oC. For co-transformation experiments, 1 mL of the
Agrobacterium culture (A600nm = 0.1) was added to
20 mL MS liquid medium (Murashige & Skoog, 1962).
Twenty leaf explants were incubated with the
Agrobacterium culture in a Petri dish for 5 min, at room
temperature. Explants were then immediately placed on
MS solid medium (0.7% agar) for two days in darkness
at 28±2oC. For regeneration and selection, the explants
were transferred to MS solid medium (0.65% agar)
containing 1 mg/mL benzylaminopurine (BAP),
500 µg/L cefotaxime and 30 µg/mL hygromycin and
maintained under a 16 hours photoperiod at 25±2oC.
Untransformed explants were placed onto the same
medium with or without hygromicin as the negative and
positive controls, respectively. Shoots regenerated on
selection medium were excised at the base and placed
in Magenta GA7 boxes containing rooting medium (the
same medium as the regeneration medium but without
BAP). The hygromycin-resistant plants tested by PCR
using both 3’ and 5’ α-AI2 and hygromycin
primers were transferred to soil and grown in a
greenhouse at 25±10oC and 50% humidity.
The mature seeds were collected after 4 months.
Protein extraction
The soluble wild type and recombinant proteins
expressed in tobacco seeds, were extracted as
previously described (Grossi-de-Sá et al., 1997) by
grinding 150 mg of dry seeds, in an ice-cold mortar with
1.0 mL 50 mM Tris-HCl, pH 8.0, containing 0.1% Triton
X-100, 30 mM NaCl and 1% 2-mercaptoethanol. The
homogenates were twice centrifuged for 10 minutes at
the top speed of a bench centrifuge and the supernatants
stored at -20oC or immediately used to measure the
inhibitory activity. Protein concentration was determined
according to Bradford (1976) using bovine serum albumin
as standard.
Electrophoresis and immunobloting
Tricine polyacrylamide gel electrophoresis (Tricine/
PAGE), 12% polyacrylamide, was performed according
to Schagger & Jagow (1987). After separation by
Tricine/PAGE, polypeptides were transferred onto a
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nitrocellulose membrane and incubated with a 1:1000
dilution of a polyclonal antibody rabbit serum raised
against α-AI1 (Grossi-de-Sá et al., 1997).
Immunoglobulin G coupled to horseradish peroxidase
HRP was used as a secondary antibody and the reaction
was visualized using 0.1% (v/v) H2O2 in TBS buffer
(Koncz & Schell, 1986) mixed with 3% (w/v) HRP color
development reagent in methanol.
Alpha-amylase inhibition assay
The α-amylase activity was measured using the
dinitrosalicylic acid (DNS) method adapted from
Bernfeld (1955) and Ishimoto & Chrispeels (1996) using
1% soluble starch as substrate. To measure inhibitory
activity of tobacco seed extracts against either PPA or
ZSA expressed in Sf9 insect cells, the solutions containing
200 µg of the total extract (previously analyzed in
immunoblots) and one unit α-amylase activity (defined
as the amount of this enzyme that increased the
absorbance at 546 nm by 0.1 absorbance units during
25 minutes) were pre-incubated at room temperature
for 20 minutes prior to the addition of 250 µL of the
substrate solution followed by incubation at 37oC for
10 minutes. The reactions were stopped by the addition
of 500 µL of DNS reagent followed by color
development, placing the tubes in boiling water for
10 minutes. After addition of 5 mL distilled water, the
absorbance was read at 546 nm. Alfa-amylase inhibitor-1
purified from P. vulgaris was used as positive and
negative controls in assays with PPA and ZSA,
respectively. Assays were carried out in duplicate.
Duplicate inhibition values differed by no more
than 10%.
Computational methods
In order to study the behavior of mutant M1 in
structural terms, four model complexes, PPA-α-AI2,
PPA-M1, ZSA-α-AI2 and ZSA-M1, using
MODELLER (Sali & Blundell, 1993) were constructed.
Experimental results show that the M1 complexes are
merely hypothetical, i.e., do not actually form. Since the
patterns of inhibition of M2-4 were identical to that of
M1, these other mutants were not studied further. The
structure of PPA in complex with α-AI1, PDB code
1DHK (Bompard-Gilles et al., 1996) was used to
construct the PPA-α-AI2 and PPA-M1 model
complexes while the structure of TMA in complex with
α-AI1, PDB code 1VIW (Nahoum et al., 1999) was
used for modeling ZSA-α-AI2 and ZSA-M1. Alignments
were adjusted so that insertions and deletions in the model
proteins relative to the templates could be smoothly
accommodated. In each case, ten variant models were
constructed and refined against MODELLER’s objective
function which measures the models agreement with
template-derived restraints, in combination with the
standard CHARM energy function.
The best performing model (that with the lowest
objective function) for each of the complexes was taken
as the respective final model. Each final model complex
was analysed, and compared with the crystal structure
of PPA in complex with wild-type α-AI1, using the
protein-protein interaction server (Jones & Thornton,
2001). This server determines which residues in a protein
complex contribute with the surface areas of the interface
and measures geometrical characteristics of the interface
which can then be compared with typical values (Jones
& Thornton, 1996). Visualization of protein structures
was carried out using O (Jones et al., 1991) and Pymol
(Delano, 2001) programs.
Results and Discussion
The major interaction between α-AI1 and PPA, as
revealed by the crystal structure of the complex, is via
two loops of α-AI1 that make numerous hydrogen bonds
with the amino acids in the substrate cleft of PPA
(Bompard-Gilles et al., 1996; Silva et al., 2000). To assess
the role of the two loops for the specificity of
α-AI-amylase interaction, chimeric amylase inhibitor was
made containing specific changes based on modeling
experiments (Silva et al., 2000). Analyzing the full set of
previously identified interface-forming residues, four
mutants were designed (Table 1). The mutated amino
acids were chosen for their putative importance in
electrostatic and hydrophobic aspects of the enzyme-
inhibitor interaction. One option would have been the
simple mutation of putatively important residues to amino
Table 1. Aminoacid sequence involved on the mutations(1).
(1)Numbering as processed in Silva et al. (2000).(2)-- Indicating absence
of two residues in this loop.
M4
Aminoacid sequences Interface forming residues (IFR)
N-terminal
loop
C-terminal
loop
Wild type inhibitors
α-AI1
α-AI2
33SYN35
 --H33(2)
H73 177YQWSY181
Q71 175HEYSF179
α-AI2 mutant inhibitors
M1
M2
M3
33SYN35
33SYN35
33SYN35
33SYN35
Q73
Q73
H73
H73
177HEYSF181
177HEYSF181
177YQWSY181
177YQWSY181
Outside of
the loops
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acids of different physicochemical characteristics, or
simply to alanine, and the monitoring of the consequent
loss of ZSA inhibition. Instead, the chosen residues were
mutated to their α-AI1 counterparts so that, in addition
to loss of ZSA inhibition, possible acquisition of PPA
inhibition could be monitored. Through this dual assay
approach, it was expected that an enhanced
understanding of the detailed importance of the mutated
residues would be achieved.
The PCR products of wild-type and mutant genes
were ligated to 5’ regulatory sequence of PHA-L,
because of known success of this seed-specific
promoter in expressing the α-AI activity in plants
(Altabella & Chrispeels, 1990). Therefore, all chimeric
construction as well as wild-type form of α-AI2 were
expressed in tobacco seeds. Since α-AI1 needs to be
proteolytically processed to be active, plant expression,
leading to proper glycosylation and proteolytic
processing, was essential (Altabella & Chrispeels, 1990;
Pueyo et al., 1993). Approximately 15–20 independent
transgenic plants (tested by PCR) were obtained for
each construction.
Four transgenic lines for each construction were used
to perform immunoblots with serum raised against
α-AI1. The level of transgene expression was
approximately equal to all mutants. The similar
polypeptide profiles observed in the 12–15 kDa range
to tobacco seeds expressing the recombinant proteins
and wild-type inhibitor demonstrate that mutations did
not destabilize the proteins to a point where they were
degraded by endogenous proteases (Figure 1).
To investigate the specificity of the recombinant
proteins accumulated in tobacco seeds in relation to
α-amylases, total extracts were tested for inhibitory
activity against PPA and ZSA. To circumvent possible
stability problems, the proteins expressed in tobacco
seeds were tested immediately after the preceding
extraction. In agreement with previous reports (Suzuki
et al., 1993; Grossi-de-Sá et al., 1997, Grossi-de-Sá &
Chrispeels, 1997) α-AI1 inhibited PPA but not ZSA, and
α-AI2 inhibited ZSA, but not PPA. However, all the
mutants lost inhibitory activity against ZSA and none of
the mutants acquired specificity toward PPA (Figure 2).
Because the level of the expression varied between
mutant and wild-type proteins (Figure 1), different
concentrations were used in the assays to assess the
activity of the mutated proteins.
The high sequence identity between modeled proteins
and templates (78% between α-AI1 and α-AI2; 61%
for the comparison of ZSA and TMA) along with careful
manual positioning of insertions and deletions, ensure
reliable models. In the cases of the ZSA complexes, the
present models should be significantly more accurate
than those previously analysed (Silva et al., 2000) since
they were based on the TMA-α-AI1 (Nahoum et al., 1999)
Figure 2. Activities of α-AI1and α-AI2(a), extracted from
Phaseolus vulgaris, α-AI2(b) and mutants, extracted from
transformed tobacco seeds, in relation to ZSA and PPA. NT
refers to seed extract from untransformed tobacco. The enzyme
activity values were calculated for four transformed lines for
each mutant. In each of (a) and (b) the highest activity obtained
was defined as 100% and the remaining results expressed as
percentages.
Figure 1. Immunoblot of the α-AI2 and mutants expressed in
tobacco seeds. 87.5 µg of the total protein was loaded in each
lane. α-AI2a refers to an inhibitor purified from Phaseolus
vulgaris and α-AI2b to an inhibitor expressed in tobacco seeds
while M1, M2, M3 and M4 refer to α-AI2 mutants. NT refer to
untransformed plant (negative control). Molecular weight
standard are shown on the left.
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complex rather than on the structure of α-AI1 alone.
Comparison of the structures of complexed and
uncomplexed α-AI1 models reveals significant
differences in the conformations of loops that interact
with α-amylase.
Attempts to model a ZSA-M1 complex revealed
unnaturally close atomic contacts between ZSA and M1
in the region of the latter’s α-AI1-like two residues
insertion. Comparison with the TMA-α-AI1 crystal
structure shows that these clashes arise mainly from
the substitution of Thr291 (TMA numbering) with the
larger Asp and from different backbone structure of the
loop around residue 293 which is one residue shorter in
ZSA than in TMA (Figure 3). As well as the steric aspect,
it is notable that Asp 291 in ZSA is largely buried in the
hypothetical interface with M1, distant from any positive
charge with which to interact. In contrast, in the modeled
complex with α-AI2, charge compensation is provided
in the form of His33 (Figure 3). These results are
consistent with the inhibition of TMA (but not ZSA) by
α-AI1 and ZSA (but not TMA) by α-AI2 (Suzuki et al.,
1993; Nahoum et al., 1999).
The inability of α-AI2 or M1 to inhibit PPA is consistent
with the geometric analyses of the hypothetical
complexes obtained from the protein-protein interaction
server. The server measures surface complementarity
as a gap volume index (Jones & Thornton, 1996). Lower
values indicate better complementarity and typical values
for experimentally determined enzyme-inhibitor
complexes are 2.2±0.5. The values obtained for the two
crystal structures of α-amylase-inhibitor complexes are
2.2 and 2.3. In sharp contrast, the hypothetical
PPA-M1 and PPA-α-AI2 complexes score 2.7 and 3.0,
respectively, at the limit or outside the typical range.
These poorer complementarity values presumably
contribute to the lack of PPA inhibition by α-AI2 or M1,
although other factors may also be involved.
The most striking finding reported is the absence of
inhibition of ZSA by M1 which differs from wild-type
α-AI2 only in the replacement of His33 with
Ser-Tyr-Asn. The explanation obtained through modeling
involved combined steric and electrostatic effects.
Hence, the alteration in α-AI2 structure produced a
drastic change in inhibitory behavior through two distinct
mechanisms. This result follows other examples of
apparently fine-tuned α-amylase inhibitor specificity
(Franco et al., 2000). The multiple factors underlying
amylase inhibitor specificity have been reviewed recently
(Franco et al., 2002).
The lack of appearance of PPA inhibition even in M4
is explained by consideration of the complexity of the
PPA-α-AI1 interface. Eight inhibitor segments
containing one to ten residues each contribute to the
interface with PPA. This is more than double the number
of inhibitor segments typically involved in enzyme-
inhibitor interfaces (3±0.9 segments). The size of the
interface area between PPA-α-AI1 (1,430 Å2) is much
larger than the average for enzyme-inhibitor complexes
(785±75 Å2). These analyses show that the interface
between PPA and α-AI1 is larger and more complex
than typical enzyme-inhibitor interfaces. This naturally
makes more difficult the task of precisely determining
all the factors involved in conferring specificity for
α-AI1 or α-AI2 on a given α-amylase (Silva et al.,
2000). Even in the most-changed mutant M4, only 41%
of the inhibitor surface area in the PPA-α-AI1 complex
has been grafted into the α-AI2 environment.
Conclusions
1. The first interacting loop of the inhibitors is an
important contributor to specificity but other factors also
exist.
2. Computational analyses are useful for highlighting
important interface residues and analyzing the results of
their mutation.
Figure 3. Structural comparison of the ZSA-α-AI2 (white)
and ZSA-M1 (green, thinner bonds and smaller atoms)
complexes near the side of mutation. The additional two
residues present in M1 compared to α-AI2 cause steric clashes
with Asp 291 of ZSA as marked by the broad green dotted
line. With α-AI2, in contrast, a favorable ionic interaction
with His 32 is present. The extra residues do not clash with
the Thr (black) that replaces Asp 291 in TMA.
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3. The interaction between α-AI and α-amylases is
atypically complex so that additional work will be
required to fully understand all specificity determinants.
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